 "Kejriwal lauds scientists and doctors after DCGI nod to two Covid vaccines")
Delhi Chief Minister Arvind Kejriwal on Sunday said that approval for the emergency use of two "made in India" vaccines will give a positive direction to the country's fight against coronavirus.
Congratulating the countrymen, Kejriwal saluted the scientists and doctors for the achievement.
The Drugs Controller General of India (DCGI)on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.
"Congratulations to all the countrymen.Approval by DCGI to emergency use of two made in India vaccines will give a positive direction to the country's fight against corona. Salute to the scientists and doctors whose hard work helped us reach here," Kejriwal tweeted in Hindi.
The approval was granted by the DCGI following the recommendation by the COVID-19 Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).
This paves the way for the roll-out of at least two vaccines in India in the coming days and a massive inoculation drive against the coronavirus that has claimed over 1.49 lakh lives in the country.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app